L.G. Paz-Ares: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

SEOM guidelines for the management of non-small-cell lung cancer (NSCLC)

Enriqueta Felip, Pilar Garrido, José Manuel Trigo, Marta López-Brea, Luis Paz-Ares, Mariano Provencio, Dolores Isla, SEOM Guidelines Working Group

Journal:

Clinical and Translational Oncology

Year:

2009

Language:

english

File:

PDF, 686 KB

english, 2009

52

Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients

Alfredo Carrato Mena, Luis Paz-Ares Rodríguez, Álvaro Rodríguez Lescure, Ana M. Casas Fernández de Tejerina, Eduardo Díaz Rubio García, Pedro Pérez Segura, Manuel Constenla Figueiras, Rocío García Car

Journal:

Clinical and Translational Oncology

Year:

2009

Language:

english

File:

PDF, 484 KB

english, 2009

53

Inhibiting PI3K as a therapeutic strategy against cancer

Luis Paz-Ares, Carmen Blanco-Aparicio, Rocío García-Carbonero, Amancio Carnero

Journal:

Clinical and Translational Oncology

Year:

2009

Language:

english

File:

PDF, 445 KB

english, 2009

54

Expression of EGFR, HER-2/neuand KIT in germ cell tumours

Ignacio Durán, Adelaida García-Velasco, Claudio Ballestín, Elena García, Francisco Martínez-Tello, Gregory R. Pond, Rocío García-Carbonero, Hernán Cortés-Funés, Luis Paz-Ares

Journal:

Clinical and Translational Oncology

Year:

2010

Language:

english

File:

PDF, 426 KB

english, 2010

55

A cost-effectiveness analysis of sunitinib in patients with metastatic renal cell carcinoma intolerant to or experiencing disease progression on immunotherapy: perspective of the Spanish National Health System

L. Paz-Ares, J. G. Del Muro, E. Grande, S. Díaz

Journal:

Journal of Clinical Pharmacy and Therapeutics

Year:

2010

Language:

english

File:

PDF, 170 KB

english, 2010

56

Interallelic complementation at the Arabidopsis CRE1 locus uncovers independent pathways for the proliferation of vascular initials and canonical cytokinin signalling

Berenice García-Ponce De León, Jose Manuel Franco Zorrilla, Vicente Rubio, Preeti Dahiya, Javier Paz-Ares, Antonio Leyva

Journal:

The Plant Journal

Year:

2004

Language:

english

File:

PDF, 260 KB

english, 2004

57

Dissection of local and systemic transcriptional responses to phosphate starvation in Arabidopsis

Marie-Christine Thibaud, Jean-François Arrighi, Vincent Bayle, Serge Chiarenza, Audrey Creff, Regla Bustos, Javier Paz-Ares, Yves Poirier, Laurent Nussaume

Journal:

The Plant Journal

Year:

2010

Language:

english

File:

PDF, 501 KB

english, 2010

58

A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion

Paz-Ares, L, Kunka, R, DeMaria, D, Cassidy, J, Alden, M, Beranek, P, Kaye, S, Littlefield, D, Reilly, D, Depee, S

Journal:

British Journal of Cancer

Year:

1998

Language:

english

File:

PDF, 1.21 MB

english, 1998

59

Target mimicry provides a new mechanism for regulation of microRNA activity

Franco-Zorrilla, José Manuel, Valli, Adrián, Todesco, Marco, Mateos, Isabel, Puga, María Isabel, Rubio-Somoza, Ignacio, Leyva, Antonio, Weigel, Detlef, García, Juan Antonio, Paz-Ares, Javier

Journal:

Nature Genetics

Year:

2007

Language:

english

File:

PDF, 390 KB

english, 2007

60

IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer

Ibanez de Caceres, I, Cortes-Sempere, M, Moratilla, C, Machado-Pinilla, R, Rodriguez-Fanjul, V, Manguán-García, C, Cejas, P, López-Ríos, F, Paz-Ares, L, de CastroCarpeño, J

Journal:

Year:

2009

Language:

english

File:

PDF, 757 KB

english, 2009

61

Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer

del Muro, X García, Marcuello, E, Gumá, J, Paz-Ares, L, Climent, M A, Carles, J, Parra, M Sánchez, Tisaire, J L, Maroto, P, Germá, J R

Journal:

British Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 80 KB

english, 2002

62

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

Paz-Ares, L, Ross, H, O'Brien, M, Riviere, A, Gatzemeier, U, Von Pawel, J, Kaukel, E, Freitag, L, Digel, W, Bischoff, H

Journal:

British Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 143 KB

english, 2008

63

Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab

Gualberto, A, Hixon, M L, Karp, D D, Li, D, Green, S, Dolled-Filhart, M, Paz-Ares, L G, Novello, S, Blakely, J, Langer, C J

Journal:

British Journal of Cancer

Year:

2010

Language:

english

File:

PDF, 527 KB

english, 2010

64

Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors

M.J.A. de Jonge, J.P. Droz, L. Paz-Ares, A.T. van Oosterom, R. de Wit, P. Chollet, B. Baron, D. Lacombe, K. Mettinger, P. Fumoleau

Journal:

Investigational New Drugs

Year:

2004

Language:

english

File:

PDF, 55 KB

english, 2004

65

Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors

Paz-Ares, L. G., Gomez-Roca, C., Delord, J.-P., Cervantes, A., Markman, B., Corral, J., Soria, J.-C., Berge, Y., Roda, D., Russell-Yarde, F.

Journal:

Journal of Clinical Oncology

Year:

2011

Language:

english

File:

PDF, 192 KB

english, 2011

66

Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)

Pilar Garrido, Javier de Castro, Ángel Concha, Enriqueta Felip, Dolores Isla, Fernando López-Ríos, Luis Paz-Ares, José Ramírez, Julián Sanz, José Javier Gómez

Journal:

Clinical and Translational Oncology

Year:

2012

Language:

english

File:

PDF, 483 KB

english, 2012

67

Biological markers of cisplatin resistance in advanced testicular germ cell tumours

Adelaida García-Velasco, Ignacio Durán, Elena García, Miquel Tarón, Claudio Ballestín, Daniel Castellanos, Hernán Cortés-Funés, Luis Paz-Ares

Journal:

Clinical and Translational Oncology

Year:

2012

Language:

english

File:

PDF, 712 KB

english, 2012

68

PARAMOUNT : phase 3 comparant un traitement (ttt) de maintenance par Pemetrexed (Pem) plus soins de support (BSC) versus placebo plus BSC après un ttt d’induction par Pem-Cisplatine (Cispt) dans les CBNPC non épidermoïdes avancés

J.-L. Pujol, L. Paz-Ares, F. Demarinis, M. Dediu, M. Thomas, O. Molinier, P. Bidoli, T.-P. Sahoo, E. Laack, M. Reck, C. El Kouri, L. Favier, J. Corral, Y. Martinet, S. Melemed, W. John, A. Zimmermann,

Journal:

Revue des Maladies Respiratoires

Year:

2012

Language:

french

File:

PDF, 52 KB

french, 2012

69

Pemetrexed in bladder, head and neck, and cervical cancers

Luis Paz-Ares, Eva Ciruelos, Rocío García-Carbonero, Daniel Castellano, Ana Lopez-Martín, Hernán Cortés-Funes

Journal:

Seminars in Oncology

Year:

2002

Language:

english

File:

PDF, 82 KB

english, 2002

70

Mandatory rotation of company auditors: A critical examination

Benito Arruñada, Cándido Paz-Ares

Journal:

International Review of Law and Economics

Year:

1997

Language:

english

File:

PDF, 2.18 MB

english, 1997

71

MYB transcription factors in plants

Cathie Martin, Javier Paz-Ares

Journal:

Trends in Genetics

Year:

1997

Language:

english

File:

PDF, 848 KB

english, 1997

72

Clinical Pattern and Therapeutic Results Achieved in 1490 Patients with Germ-Cell Tumours of the Testis: the Experience of the Spanish Germ-Cell Cancer Group (GG)

J.R Germà-Lluch, X Garcia del Muro, P Maroto, L Paz-Ares, J.A Arranz, J Gumà, E Alba, J Sastre, J Aparicio, A Fernández, A Barnadas, J Terrassa, A Sáenz, D Almenar, M López-Brea, M.A Climent, M.A Sánc

Journal:

European Urology

Year:

2002

Language:

english

File:

PDF, 416 KB

english, 2002

73

Article Reviews

Daniel George, Luis Paz-Ares, William K. Oh

Journal:

The Prostate Journal

Year:

2000

Language:

english

File:

PDF, 202 KB

english, 2000

74

Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

Luis Paz-Ares, Denis Soulières, Ivan Melezínek, Joachim Moecks, Lorenz Keil, Tony Mok, Rafael Rosell, Barbara Klughammer

Journal:

Journal of Cellular and Molecular Medicine

Year:

2010

Language:

english

File:

PDF, 746 KB

english, 2010

75

Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)

Luis Paz-Ares, Joachim Moecks, Barbara Klughammer

Journal:

Journal of Cellular and Molecular Medicine

Year:

2011

Language:

english

File:

PDF, 400 KB

english, 2011

76

Tratamiento multimodal en el carcinoma broncogénico no microcítico (N2) clínico: ¿cuál es la respuesta?

A. López-Encuentra, J.L. Martín de Nicolás, L. Paz-Ares, A. Bartolomé

Journal:

Archivos de Bronconeumología

Year:

2006

File:

PDF, 104 KB

2006

77

Cloning and nucleotide sequence of a cDNA encoding the precursor of the barley toxin α-hordothionin

Fernando PONZ, Javier PAZ-ARES, Carlos HERNÁNDEZ-LUCAS, Francisco GARCÍA-OLMEDO, Pilar CARBONERO

Journal:

Year:

1986

Language:

english

File:

PDF, 639 KB

english, 1986

78

A dimeric inhibitor or insect α-amylase from barley : Cloning of the cDNA and identification of the protein

Ana LÁZARO, Rosa SANCHEZ-MONGE, Gabriel SALCEDO, Javier PAZ-ARES, Pilar CARBONERO, Francisco GARCÍA-OLMEDO

Journal:

Year:

1988

Language:

english

File:

PDF, 593 KB

english, 1988

79

Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non-Small-Cell Lung Cancer

Paz-Ares, L. G., Biesma, B., Heigener, D., von Pawel, J., Eisen, T., Bennouna, J., Zhang, L., Liao, M., Sun, Y., Gans, S., Syrigos, K., Le Marie, E., Gottfried, M., Vansteenkiste, J., Alberola, V., St

Journal:

Journal of Clinical Oncology

Year:

2012

Language:

english

File:

PDF, 163 KB

english, 2012

80

Polyadenylation site heterogeneity in mRNA encoding the precursor of the barley toxin β-hordothionin

Carlos Hernández-Lucas, Joaquin Royo, Javier Paz-Ares, Fernando Ponz, Francisco García-Olmedo, Pilar Carbonero

Journal:

Year:

1986

Language:

english

File:

PDF, 342 KB

english, 1986

81

ceRNAs: miRNA Target Mimic Mimics

Ignacio Rubio-Somoza, Detlef Weigel, José-Manuel Franco-Zorilla, Juan Antonio García, Javier Paz-Ares

Journal:

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

82

Recommendations for the optimal management of early and advanced urothelial carcinoma

Daniel Castellano, Joan Carles, Emilio Esteban, José Manuel Trigo, Miguel Ángel Climent, José Pablo Maroto, Xavier García del Muro, Albert Font, Luis Paz-Ares, José Ángel Arranz, Joaquim Bellmunt

Journal:

Cancer Treatment Reviews

Year:

2012

Language:

english

File:

PDF, 261 KB

english, 2012

83

Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma

Salvador Martín-Algarra, Enrique Espinosa, Jordi Rubió, Juan José López López, José Luis Manzano, Lorenzo Alonso Carrión, Arrate Plazaola, Adnan Tanovic, Luis Paz-Ares

Journal:

European Journal of Cancer

Year:

2009

Language:

english

File:

PDF, 108 KB

english, 2009

84

Systemic chemotherapy in the management of malignant peritoneal mesothelioma

R. Garcia-Carbonero, L. Paz-Ares

Journal:

European Journal of Surgical Oncology (EJSO)

Year:

2006

Language:

english

File:

PDF, 126 KB

english, 2006

85

MP-22.08: Phase II study of two doses of ketoconazole (keto) in hormone refractory prostate cancer (HRPC)

O. Blanco, D. Castellano, A. Rodrı́guez-Antolı́n, L. Paz-Ares, O. Leiva

Journal:

Year:

2006

Language:

english

File:

PDF, 65 KB

english, 2006

86

Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer

J. Bellmunt, V. Guillem, L. Paz-Ares, J.L. González-Larriba, J. Carles, J. Albanell, J.M. Tabernero, H. Cortés-Funes, J. Baselga

Journal:

European Journal of Cancer

Year:

2000

Language:

english

File:

PDF, 118 KB

english, 2000

87

Randomised phase II study of BMS-275291 versus placebo in patients (pts) with stage IIIb or IV non small cell lung cancer (NSCLC) receiving paclitaxel + carboplatin (PC): National Cancer Institute of Canada clinical trials group (NCIC CTG) br.18

J. Douillard, V. Petersen, F. Shepherd, L. Paz-Ares, A. Arnold, M. Tonato, J. Ottaway, M. Davis, A. Van Vreckem, J. Humphrey, L. Seymour

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 365 KB

english, 2001

88

Phase I (PI) trials with aplidine (APL), a new marine derived anticancer compound

E. Raymond, L. Paz-Ares, M. Izquierdo, K. Belanger, J. Maroun, A. Bowman, A. Anthoney, D. Jodrell, J.P. Armand, H. Cortes-Funes, J. Germa-Lluch, C. Twelves, N. Celli, C. Guzman, J. Jimeno

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 159 KB

english, 2001

89

Ecteinascidin (ET-743) pharmacokinetics (PK)-overview of phase i and advanced phase II results

L. Lopez-Lazaro, C. can Kesteren, K. Hoekman, C. Twelves, A. Bowman, A. Taamma, A. Le Cesne, G. Demetri, P. Fumoleau, S. Aamdal, L. Paz-Ares, A. Poveda, F. Rivera, C. Sessa, H. Rosing, K. Lopez-Martin

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 162 KB

english, 2001

90

Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer

C Dittrich, B Coudert, L Paz-Ares, F Caponigro, M Salzberg, T Gamucci, X Paoletti, C Hermans, D Lacombe, P Fumoleau

Journal:

European Journal of Cancer

Year:

2003

Language:

english

File:

PDF, 108 KB

english, 2003

91

SP 135 Biomarkers for targeted therapy selection in non-small cell lung cancer (NSCLC)

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

92

First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study

Ulrich Gatzemeier, Joachim von Pawel, Ihor Vynnychenko, Petr Zatloukal, Filippo de Marinis, Wilfried EE Eberhardt, Luis Paz-Ares, Karl-Maria Schumacher, Thomas Goddemeier, Kenneth J O'Byrne, Robert Pi

Journal:

The Lancet Oncology

Year:

2011

Language:

english

File:

PDF, 220 KB

english, 2011

93

Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study

Kenneth J O'Byrne, Ulrich Gatzemeier, Igor Bondarenko, Carlos Barrios, Corinna Eschbach, Uwe M Martens, Yevhen Hotko, Cornelius Kortsik, Luis Paz-Ares, Jose R Pereira, Joachim von Pawel, Rodryg Ramlau

Journal:

The Lancet Oncology

Year:

2011

Language:

english

File:

PDF, 1.59 MB

english, 2011

94

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

Robert Pirker, Jose R Pereira, Joachim von Pawel, Maciej Krzakowski, Rodryg Ramlau, Keunchil Park, Filippo de Marinis, Wilfried EE Eberhardt, Luis Paz-Ares, Stephan Störkel, Karl-Maria Schumacher, Anj

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 872 KB

english, 2012

95

Beyond first-line NSCLC therapy: chemotherapy or erlotinib?

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 73 KB

english, 2012

96

Roles of Ubiquitination in the Control of Phosphate Starvation Responses in Plants F

Rojas-Triana, Mónica, Bustos, Regla, Espinosa-Ruiz, Ana, Prat, Salomé, Paz-Ares, Javier, Rubio, Vicente

Journal:

Journal of Integrative Plant Biology

Year:

2013

Language:

english

File:

PDF, 634 KB

english, 2013

97

Phase II study of Gemcitabine, Ifosfamide plus Vinorelbine (GIN) as a first-line chemotherapy in advanced non-small cell lung cancer (NSCLC): A promising non-cisplatin based regimen

Castellano, D, Lianes, P, Arcediano, A, Gómez-Martin, C, Ciruelos, E, Bezares, S, Amador, M.L, Paz-Ares, L, Cortés-Funes, H

Journal:

Year:

2000

Language:

english

File:

PDF, 106 KB

english, 2000

98

O-3 Randomized phase II study of the novel tubulin targetin agent, BMS-247550 (Epothilone B analogue) in the treatment of non-small cell lung cancer (NSCLC) in patients (pts) who have failed first line platinum containing therapy

Edelman, Martin J., Breton, Jean Luc, Sandler, Alan, Lara, Primo, Bonomil, Philip, LeChevalier, Thierry, Ardizzoni, Andrea, Paz-Ares, Luis, Peck, Ronald, Vansteenkiste, Johan

Journal:

Year:

2003

Language:

english

File:

PDF, 188 KB

english, 2003

99

O-56 Symptom and quality of life advantages for pemetrexed + cisplatin versus cisplatin in treatment of malignant pleural mesothelioma

Boyer, M.J., Jassem, J., Liepa, A.M., Symanowski, J.T., Kaukel, E., Denham, C.A., Paz-Ares, L., Gralla, R.J., Hnllen, P.J., Nguyen, B.

Journal:

Year:

2003

Language:

english

File:

PDF, 183 KB

english, 2003

100

O-271 Phase II randomized study of pemetrexed plus carboplatin or oxaliplatin, as front-line chemotherapy in patients with locally advanced or metastatic non-small-cell lung cancer

Scagliotti, G.V., Kortsik, C., Manegold, C., Dark, G., Crino, L., O'Brien, M.E.R., Rosell, R., Kayitalire, L., Paul, S., Paz-Ares, L.

Journal:

Year:

2003

Language:

english

File:

PDF, 185 KB

english, 2003